UNI-MB - logo
UMNIK - logo
 

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov UM. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 43
1.
  • Hyperprogression under Immu... Hyperprogression under Immunotherapy
    Frelaut, Maxime; Le Tourneau, Christophe; Borcoman, Edith International journal of molecular sciences, 05/2019, Letnik: 20, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    Immunotherapy is now widely prescribed in oncology, leading to the observation of new types of responses, including rapid disease progression sometimes reported as hyperprogression. However, only a ...
Celotno besedilo

PDF
2.
Celotno besedilo
3.
  • Pembrolizumab in cervical c... Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
    Borcoman, Edith; Le Tourneau, Christophe Therapeutic Advances in Medical Oncology, 06/2017, Letnik: 9, Številka: 6
    Book Review, Journal Article
    Recenzirano
    Odprti dostop

    Cervical cancer is the fourth most common cause of cancer-related deaths in women worldwide. With the development of detection of precancerous lesions and preventive human papillomavirus (HPV) ...
Celotno besedilo

PDF
4.
  • Patterns of Response and Progression to Immunotherapy
    Borcoman, Edith; Nandikolla, Amara; Long, Georgina ... American Society of Clinical Oncology educational book, 05/2018, Letnik: 38
    Journal Article
    Recenzirano

    Patterns of response and progression to immunotherapy may differ from those observed with drugs such as chemotherapy and molecularly targeted agents. Specifically, some patients experience a response ...
Preverite dostopnost
5.
  • Prognostic value of intratu... Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
    Neuzillet, Cindy; Marchais, Manon; Vacher, Sophie ... Scientific reports, 04/2021, Letnik: 11, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    Changes in the oral microbiome, particularly Fusobacterium nucleatum, are associated with oral squamous cell carcinoma (OSCC). F. nucleatum has been reported to modulate local immunity in cancers. We ...
Celotno besedilo

PDF
6.
  • HDAC Inhibition to Prime Im... HDAC Inhibition to Prime Immune Checkpoint Inhibitors
    Borcoman, Edith; Kamal, Maud; Marret, Grégoire ... Cancers, 12/2021, Letnik: 14, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    Immunotherapy has made a breakthrough in medical oncology with the approval of several immune checkpoint inhibitors in clinical routine, improving overall survival of advanced cancer patients with ...
Celotno besedilo

PDF
7.
  • Paradigm Change in First-Li... Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Borcoman, Edith; Marret, Gregoire; Le Tourneau, Christophe Cancers, 05/2021, Letnik: 13, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR) in combination with platinum-based chemotherapy has been for the decade standard of care for the treatment of ...
Celotno besedilo

PDF
8.
  • A phase II study of monaliz... A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
    Galot, Rachel; Le Tourneau, Christophe; Saada-Bouzid, Esma ... European journal of cancer (1990), 11/2021, Letnik: 158
    Journal Article
    Recenzirano
    Odprti dostop

    Monalizumab is a monoclonal antibody targeting the inhibitory natural killer group 2A (NKG2A) receptor localised on natural killer (NK) and T cells. Its ligand, the human leukocyte antigen E (HLA-E), ...
Celotno besedilo

PDF
9.
  • Hyperprogressive Disease du... Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis
    Kim, Jong Yeob; Lee, Keum Hwa; Kang, Jeonghyun ... Cancers, 11/2019, Letnik: 11, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    Hyperprogressive disease (HPD) is a recently acknowledged pattern of rapid tumor progression after the initiation of immune checkpoint inhibitors. HPD has been observed across various types of tumors ...
Celotno besedilo

PDF
10.
  • Inhibition of PI3K pathway ... Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
    Borcoman, Edith; De La Rochere, Philippe; Richer, Wilfrid ... Oncoimmunology, 05/2019, Letnik: 8, Številka: 5
    Journal Article
    Recenzirano
    Odprti dostop

    Although immune checkpoint inhibitors have shown improvement in survival in comparison to chemotherapy in urothelial bladder cancer, many patients still fail to respond to these treatments and actual ...
Celotno besedilo

PDF
1 2 3 4 5
zadetkov: 43

Nalaganje filtrov